| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Alkira | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $355.17M | Series C1 | 5/15/2024 | $70.21M | $402.6M | $1.72 | Tiger Global Management, Dallas Venture Capital, Geodesic Capital, LIAN Group, NextEquity Partners, Kleiner Perkins, Koch Disruptive Technologies, Sequoia Capital | ||||
 | aPriori | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $134.31M | Series E | 10/19/2023 | $28M | $309.55M | $1.00K | Vista Credit Partners | ||||
 | Arrived | Real Estate Other Real Estate | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $59.5M | Series B | 11/6/2025 | $25M | $273.34M | $26.61 | Neo, Forerunner Ventures, Bezos Expeditions, Core Innovation Capital | ||||
 | Atlas Card | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $99.62M | Series C | 4/14/2026 | $40M | $420M | $7.05 | Elad Gil, Verified Capital, 01 Advisors, Marathon Management Partners | ||||
 | Bicara Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $710.05M | Series C | 12/12/2023 | $165M | $495.55M | $1.38 | Braidwell LP, TPG, The Rise Fund, Deerfield Management, Fairmount, Aisling Capital, Red Tree Venture Capital, RA Capital Management, F-Prime Capital, Eight Roads Ventures, Invus Piper Heartland Healthcare Capital, Premji Invest, Omega Funds, Bioqube Ventures, Acorn Bioventures, Janus Henderson Investors | ||||
 | BioAge | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.42B | Series D | 2/13/2024 | $170M | $440.23M | $3.42 | Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz | ||||
 | Biz2Credit | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $61.74M | Series B | 6/4/2019 | $51.7M | $368.73M | $32.18 | WestBridge Capital, Nexus Venture Partners | ||||
 | Bluejay Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $242.24M | Series C-1 | 5/9/2024 | $1.14M | $371.77M | $6.53 | Frazier Life Sciences, RA Capital Management, T. Rowe Price, Wellington Management, Novo Holdings, RiverVest Venture Partners, Octagon Capital, Arkin Bio Ventures, HBM Healthcare Investments, Unicorn Capital | ||||
 | BlueWillow Biologics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $37.19M | Series C | 9/19/2022 | $5.9M | $34.12M | $0.09 | Undisclosed Investors | ||||
 | Calysta | Energy Clean Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $162M | Senior Series D-1 | 9/10/2021 | $34.5M | $334.61M | $0.66 | Adisseo, Aqua-Spark, WTI, BP Ventures | ||||
 | CandidPro | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $144.62M | Series A-1 | 7/11/2023 | $7.71M | $261.94M | $1.23 | Venrock, F-Prime | ||||
 | Circle Pharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $303.25M | Series E-1 | 9/16/2026 | $62.01M | $245.27M | $0.27 | The Column Group, Nextech Invest, RA Capital Management, Euclidean, Eli Lilly and Company | ||||
 | CodeSignal | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $177.61M | Series C | 9/16/2021 | $50M | $488.37M | $18.50 | Menlo Ventures, Index Ventures, Headline, A Capital | ||||
 | Credit Sesame | Fintech Personal Finance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $164.8M | Series H | 2/13/2026 | $27.25M | $179.95M | $3.75 | Undisclosed Investors | ||||
 | Diagonal Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $253M | Series B | 1/8/2026 | $125M | $447.42M | $2.70 | Sanofi Ventures, Janus Henderson Investors, Deep Track Capital, EcoR1 Capital, Logos Capital, Balyasny Asset Management, Woodline Partners, BVF Partners, Atlas Venture, Lightspeed Venture Partners, RA Capital Management, Frazier Life Sciences, Viking Global Investors, Velosity Capital, Checkpoint Capital, RV Invest, Biovision Ventures | ||||
 | Dtex | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $266.83M | Series E | 3/5/2024 | $50M | $435.13M | $2.06 | CapitalG | ||||
 | EndoQuest Robotics | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $207.22M | Series D-2 | 7/14/2025 | $30.74M | $316.22M | $0.80 | Crescent Enterprises, Dr. Fred Moll, Puma Venture Capital, UTHealth Houston | ||||
 | Fandom | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $475.67M | Series F | 9/4/2020 | $84.95M | $293.35M | $1.30 | Undisclosed Investors | ||||
 | Hyphen | Technology Hardware Other Technology Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $81.69M | Series B | 8/13/2025 | $20.72M | $292.82M | $5.46 | CAVA Group, Chipotle | ||||
 | Instrumental | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $80.63M | Series C | 2/16/2022 | $50M | $300.92M | $8.08 | BAM Elevate, Canaan, Root Ventures, Eclipse Ventures | ||||
 | ionQ | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $96.18M | Series B-1 | 10/22/2019 | $73.7M | $212.64M | $5.58 | Samsung Catalyst Fund, Mubadala Capital | ||||
 | Kindbody | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.59B | Series E-1 | 12/31/2024 | $79.37M | $420.77M | $3.73 | Undisclosed Investors | ||||
 | Kneron | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $107.50K | -- | 1 | Not available | -- | -- | $32.88M | Series A-1 | 5/31/2018 | $17.88M | $142.69M | $2.86 | Horizons Ventures | ||||
 | Landing | Consumer & Lifestyle Travel & Hospitality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $212.07M | Series C-3 | 3/22/2024 | $22M | $443.37M | $22.21 | Undisclosed Investors | ||||